Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2000
Business Overview: The Company operates 131 outpatient physical and occupational therapy clinics across 30 states, providing post-operative care and treatment for orthopedic and sports-related injuries. As of June 30, 2000, the average age of clinics was 3.62 years. The Company discontinued its surgery center initiative in March 2000 to focus exclusively on therapy business growth.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 30, 2000 |
Six Months Ended June 30, 2000 |
|---|---|---|
| Net Revenues | $15,825 | $30,647 |
| Operating Income | $2,653 | $4,761 |
| Net Income | $938 | $1,609 |
| Diluted EPS | $0.26 | $0.45 |
| Cash and Equivalents | $5,323 (as of June 30, 2000) | |
| Net Cash from Operations | ||
| Debt (Convertible Notes) | $8,050 (Principal Amount) | |
| Current Ratio | 6.32 to 1.00 |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 23% ($2.8M) for the quarter and 24% ($5.9M) for the six months compared to the prior year periods. Growth was driven by 29 new clinics (contributing 49% of Q2 revenue growth) and a 11-14% increase in patient visits at existing clinics.
- Profitability: Net income rose 52% for the quarter and 49% for the six months. Operating margins improved as clinic operating costs as a percentage of revenue decreased from 74% to 72% (Q2) and 75% to 72% (Six Months).
- Cost Structure: Salaries and related costs increased 18% (Q2) and 17% (Six Months), primarily due to new clinic openings and increased staffing. Recruitment and development costs surged 70% for the six months, largely due to $329,000 in costs associated with the discontinued surgery center initiative.
- Liquidity: Cash and cash equivalents increased by $1.3M to $5.3M, driven by strong operating cash flows of $4.3M, partially offset by capital expenditures of $1.6M and minority investor distributions of $1.5M.
Guidance, Outlook, and Risks
- Strategic Shift: The Company discontinued its surgery center initiative in March 2000, incurring $329,000 in costs, to focus 100% on the growth of its therapy business.
- Expansion Goals: The Company aims to open 26 new clinics in 2000. Management expects initial operating losses from new clinics but anticipates favorable long-term impact based on historical performance.
- Stock Repurchase: On July 11, 2000, the Company commenced an offer to purchase up to 500,000 shares at $11.00 per share. Preliminary results indicated 655,486 shares tendered; the Company intends to purchase approximately 565,000 shares for ~$6.2M, funded by cash and a new $2.5M bank loan.
- Regulatory Environment: The Company notes the impact of the Balanced Budget Act of 1997 and the 1999 Refinement Act, which placed a two-year moratorium on the $1,500 Medicare reimbursement limit for therapy services.
- Accounting Standards: The Company is preparing to adopt SFAS 133 (Derivatives) in 2001 and SAB 101 (Revenue Recognition) in Q4 2000; the impact of SAB 101 and FIN 44 has not yet been determined.
Investor Verification Checklist
- Stock Repurchase Execution: Verify the final number of shares repurchased and the total cost of the tender offer announced in July 2000.
- Debt Financing: Confirm the terms and drawdown status of the $2.5M convertible line of credit and $500,000 revolving credit facility secured to fund the stock buyback.
- Medicare Reimbursement: Monitor the expiration of the two-year moratorium on the $1,500 Medicare therapy cap and its potential impact on future revenue.
- Accounting Impact: Review the Q4 2000 filing for the financial impact of implementing SAB 101 regarding revenue recognition.
- Clinic Performance: Assess the profitability timeline of the 19 clinics opened in the first half of 2000 to ensure they meet historical ramp-up expectations.